VEGFC and lymphedema: Several groups have investigated the utility of lymphangiogenic growth factors such as VEGF-C in overcoming the effects of radiotherapy injury to LEC, aiming to mitigate the clinical outcome of lymphoedema (Goldman et al., 2005; Padera et al., 2008; Kesler et al., 2013; Padera et al., 2015).